Document is current
Any future updates will be listed below
-
Authors
Bamba, Takeo
Kato, Ken
Daiko, Hiroyuki
Ito, Yoshinori
Kajiwara, Takeshi
Fujita, Takeo
Miyata, Hiroshi
Machida, Ryunosuke
Sasaki, Keita
Takeuchi, Hiroya
Kitagawa, Yuko
- License Information
-
More Information
Article History
First Online: 2 June 2025
Disclosures
: Takeshi Kajiwara—honoraria for lectures: Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Bristol-Myers Squibb K.K., Taiho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Daiichi Sankyo Co., Ltd. Yuko Kitagawa—Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., Tsumura and Co., Eisai Co., Ltd., Takeda Pharmaceutical Co., Ltd., Kaken Pharmaceutical Co., Ltd., Sumitomo Pharma Co., Ltd., Otsuka Pharmaceutical Factory Inc., Kyouwa Hakkou Kirin Co., Ltd., Teijin Pharma Limited, and Kowa Company, Ltd. This work has received funding from Asahi Kasei Pharma Corporation, Astrazeneca K.K., Ethicon Inc., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Olympus Corporation, Cardinal Health K.K., Shionogi and Co., Ltd., Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Bristol-Myers Squibb K.K., MSD K.K., Smith and Nephew K.K., Kaken Pharmaceutical Co., Ltd., Aska Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co. Ltd., Toray Industries, Inc., Daiichi Sankyo Company, Limited, Chugai Foundation For Innovative Drug Discovery Science, Nippon Kayaku Co., Ltd., EA Pharma Co., Ltd., Intuitive Surgical G.K., Takeda Pharmaceutical Company Limited, Sysmex Corporation, Tsumura and Co., Ai Medical Service Inc., Kowa Company, Ltd., Eisai Co., Ltd., Joint Research Laboratory for Development and Education of Innovative Medical Technology, Sysmex Corporation, and Medicaroid Corporation.
